These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 14609294)

  • 21. Yellow coloration phenomena of incorporated indomethacin into folded sheet mesoporous materials.
    Tanabe S; Higashi K; Umino M; Limwikrant W; Yamamoto K; Moribe K
    Int J Pharm; 2012 Jun; 429(1-2):38-45. PubMed ID: 22446085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anomalous role change of tertiary amino and ester groups as hydrogen acceptors in eudragit E based solid dispersion depending on the concentration of naproxen.
    Ueda H; Wakabayashi S; Kikuchi J; Ida Y; Kadota K; Tozuka Y
    Mol Pharm; 2015 Apr; 12(4):1050-61. PubMed ID: 25654583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of properties and recrystallisation behaviour of amorphous indomethacin samples prepared by different methods.
    Karmwar P; Graeser K; Gordon KC; Strachan CJ; Rades T
    Int J Pharm; 2011 Sep; 417(1-2):94-100. PubMed ID: 21182910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved physical stability of amorphous state through acid base interactions.
    Telang C; Mujumdar S; Mathew M
    J Pharm Sci; 2009 Jun; 98(6):2149-59. PubMed ID: 18837038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture.
    Rumondor AC; Marsac PJ; Stanford LA; Taylor LS
    Mol Pharm; 2009; 6(5):1492-505. PubMed ID: 19634917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physicochemical investigations on the structure of drug-free and drug-loaded solid lipid nanoparticles (SLN) by means of DSC and 1H NMR.
    Zimmermann E; Souto EB; Müller RH
    Pharmazie; 2005 Jul; 60(7):508-13. PubMed ID: 16076076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of polymer concentration on the molecular mobility and physical stability of nifedipine solid dispersions.
    Kothari K; Ragoonanan V; Suryanarayanan R
    Mol Pharm; 2015 May; 12(5):1477-84. PubMed ID: 25894099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of crystalline disorder in cryo-milled samples of indomethacin using atomic pair-wise distribution functions.
    Bøtker JP; Karmwar P; Strachan CJ; Cornett C; Tian F; Zujovic Z; Rantanen J; Rades T
    Int J Pharm; 2011 Sep; 417(1-2):112-9. PubMed ID: 21182911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigating miscibility and molecular mobility of nifedipine-PVP amorphous solid dispersions using solid-state NMR spectroscopy.
    Yuan X; Sperger D; Munson EJ
    Mol Pharm; 2014 Jan; 11(1):329-37. PubMed ID: 24256090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Miniaturized screening of polymers for amorphous drug stabilization (SPADS): rapid assessment of solid dispersion systems.
    Wyttenbach N; Janas C; Siam M; Lauer ME; Jacob L; Scheubel E; Page S
    Eur J Pharm Biopharm; 2013 Aug; 84(3):583-98. PubMed ID: 23395968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on the crystallinity of a pharmaceutical development drug substance.
    Byard SJ; Jackson SL; Smail A; Bauer M; Apperley DC
    J Pharm Sci; 2005 Jun; 94(6):1321-35. PubMed ID: 15858842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metastability and instability of organic crystalline substances.
    Randzio SL; Kutner A
    J Phys Chem B; 2008 Feb; 112(5):1435-44. PubMed ID: 18189384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular modeling as a predictive tool for the development of solid dispersions.
    Maniruzzaman M; Pang J; Morgan DJ; Douroumis D
    Mol Pharm; 2015 Apr; 12(4):1040-9. PubMed ID: 25734898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization and stability of solid dispersions based on PEG/polymer blends.
    Bley H; Fussnegger B; Bodmeier R
    Int J Pharm; 2010 May; 390(2):165-73. PubMed ID: 20132875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Some aspects of solid-state stability and diffuse reflectance spectroscopy.
    Pope DG; Lach JL
    Pharm Acta Helv; 1975; 50(6):165-77. PubMed ID: 1101274
    [No Abstract]   [Full Text] [Related]  

  • 36. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
    Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of copolymer composition on the phase behavior of solid dispersions.
    Prudic A; Kleetz T; Korf M; Ji Y; Sadowski G
    Mol Pharm; 2014 Nov; 11(11):4189-98. PubMed ID: 25295846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early drug development predictions of glass-forming ability and physical stability of drugs.
    Mahlin D; Bergström CA
    Eur J Pharm Sci; 2013 May; 49(2):323-32. PubMed ID: 23557841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of qualitative and quantitative analysis methods in pharmaceutical application with new selective signal excitation methods for 13 C solid-state nuclear magnetic resonance using 1 H T1rho relaxation time.
    Nasu M; Nemoto T; Mimura H; Sako K
    J Pharm Sci; 2013 Jan; 102(1):154-61. PubMed ID: 23147444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation and transformation of true nifedipine polymorphs: investigated with differential scanning calorimetry and X-Ray diffraction pattern fitting methods.
    Grooff D; Liebenberg W; De Villiers MM
    J Pharm Sci; 2011 May; 100(5):1944-57. PubMed ID: 21259235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.